Orca1

FDA inspection

Pfizer Pharmaceutical Llc.: FDA inspection ending May 26, 2005

FDA inspection 384445 · Voluntary Action Indicated (VAI) · Barceloneta, PR

Key facts

Inspection ID 384445
Firm Pfizer Pharmaceutical Llc.
FEI number 2650011
Address Hwy #2 Rd 140 Km 64.4
City Barceloneta
State PR
ZIP 00617
Fiscal year 2005
Inspection end date May 26, 2005
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation|New Drug Evaluation|OTC Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Other inspections at this establishment

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections